Riskpilot← Back to searchSign inGet full accessFISCHER MEDICAL ApS
APSActiveCVR 20250704Ellekær 9, st. thWholesale of pharmaceutical and medical goods · NACE 4646Est. 19979 employeeswww.fischermedical.dk
Revenue 2025
DKK 25M
+6% vs 2024
EBITDA margin
52.4%
-2% vs 2024
Equity ratio
74.4%
Financial strength
Net profit 2025
DKK 10,2M
-1% vs 2024
| Revenue | DKK 25M | +6% |
| EBITDA | DKK 13,1M | -2% |
| Net profit | DKK 10,2M | -1% |
| Total assets | DKK 43,1M | +6% |
| Equity | DKK 32,1M | -2% |
| Employees | 9 | — |
Legal name
FISCHER MEDICAL ApS
CVR number
20250704
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 1997
Share capital
DKK 125.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at drive handel, import og eksport.
Address
Ellekær 9, st. th
Phone
+4545938100
Website
www.fischermedical.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 18.537 | 18.201 | 16.572 | 23.672 | 25.007 |
| Staff expenses | -9.066 | -7.586 | -8.383 | -10.260 | -11.901 |
| EBITDA | 9.471 | 10.610 | 8.190 | 13.412 | 13.106 |
| Depreciation & amort. | -836 | -645 | -537 | -167 | -243 |
| EBIT | 8.635 | 9.965 | 7.653 | 13.245 | 12.863 |
| Net financials | -112 | -947 | -490 | 34 | 304 |
| Profit before tax | 8.523 | 9.018 | 7.163 | 13.279 | 13.167 |
| Tax | 1.886 | 2.000 | 1.584 | 2.932 | 2.951 |
| Net profit | 6.637 | 7.018 | 5.579 | 10.347 | 10.216 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30.940 | 39.422 | 33.802 | 40.713 | 43.125 |
| Equity | 25.941 | 32.959 | 28.538 | 32.884 | 32.100 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.999 | 6.463 | 5.265 | 7.829 | 11.025 |
| Total debt | 4.999 | 6.463 | 5.265 | 7.829 | 11.025 |
EBITDA margin
52.4%
This company
15.8%
Market median
+232% vs market
20212025
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
31.8%
This company
18.4%
Market median
+73% vs market
20212025
Net profit margin
40.9%
This company
8.1%
Market median
+405% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GN Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (3) | ||
PE Chief Executive Officer | Chief Executive Officer | 2004 – 2026 |
KM Management | Management | 1997 – 1998 |
RF Management | Management | 1998 – 2004 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Chairman | 2021 – 2023 | |
| Board of Directors | 1998 – 2014 | |
| Board of Directors | 1997 – 1998 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2021 | |
| Company | 20–24.99% | 20–24.99% | 2015 | |
| Individual | 10–14.99% | 10–14.99% | 2015 | |
| Individual | 20–24.99% | 20–24.99% | 2015 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2015 | |
| Individual | 10–14.99% | 10–14.99% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FISCHER MEDICAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Espenhein | Chief Executive Officer | 0 companies |
| Kim Madsen | Management | 0 companies |
| Robert Fischer | Management | 0 companies |
| Glenn Noer | Chief Executive Officer | 0 companies |
| Roberto Blanco Riera | Board of Directors | 0 companies |
| Luca Marenzi | Chairman | 0 companies |
| Martin Almgren | Chairman | 0 companies |
| Tom Nichlas Essner | Board of Directors | 0 companies |
| Susanne Ormonde Trap Friis | Board of Directors | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |